Molecular Characteristics Molecular Type: Synthetic growth hormone fragment research peptide Structure: Linear peptide chain Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Molecular Stability and Storage Profile Supplied as a lyophilized powder for enhanced long-term stability Long-term storage: Store at 20C to preserve molecular integrity Sensitive to moisture and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Characteristics Bacteriostatic water Sterile saline Acidic buffers Compatible analytical-grade organic solvents Technical Specifications product Name AOD9604 6mg cas 386264-39-7 purity 99% (HPLC verified) unit Size 6 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear peptide chain stability High when stored appropriately Analytical Validation and Quality Control High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity and weight verification UV spectrophotometric concentration analysis Batch identity and consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement AOD9604 6mg is supplied strictly for laboratory research and scientific investigation
People with Digestive or Autoimmune Conditions Conditions such as Crohns disease, celiac disease, ulcerative colitis, and other gastrointestinal disorders can significantly impair the bodys ability to absorb nutrients, including B12
Other combinations include tirzepatide with B6 and tirzepatide with levocarnitine , each targeting specific complementary mechanisms that may enhance the overall weight loss and wellness outcome
two exceptions to this are in , where in the year 2000 oral vitamin B Canada and Sweden 12 accounted for 73% of the total vitamin B 12 prescribed
Our focus in 2026 is raising awareness of this educational tool and encouraging its use across the NHS
